Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8615572 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 6 Pages |
Abstract
The results of our study have shown that patients with < 20% cellularity and < 20% blasts on the D14 bone marrow assessment should continue observation until recovery rather than receive additional immediate therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Thomas A. Ollila, Adam J. Olszewski, James N. Butera, Matthew I. Quesenberry, Peter J. Quesenberry, John L. Reagan,